Chicago, IL—Real-world patients with mitral regurgitation (MR) not meeting the COAPT eligibility criteria who ultimately underwent clip-based transcatheter mitral valve repair fared just as well as ...
NEW YORK, NY—More postmarket registry data confirm the safety and efficacy of mitral transcatheter edge-to-edge repair (M-TEER) with MitraClip (Abbott) in patients with secondary mitral regurgitation ...
COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF
SAN DIEGO, CA (UPDATED)—It’s a shocking success for the MitraClip after years of gloomy predictions, sluggish trial enrollment, and—most of all—the negative MITRA-FR trial results last month. Today, ...
Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved clinical outcomes in patients with HF across all quartiles of mitral ...
One-year mortality rates for patients with secondary mitral regurgitation (MR) treated with the next-generation MitraClip NTR and XTR systems (Abbott) as part of the real-world, global EXPAND registry ...
Fewer than one in five patients enrolled in the COAPT trial of the MitraClip (Abbott) were “super-responders” to their assigned therapies, with more seen in the percutaneous intervention group than in ...
NEW ORLEANS, LA—A detailed look at the echocardiographic results from the COAPT trial has failed to pinpoint any baseline echocardiographic factors that could help valve teams decide which patients ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with HF with moderate to severe or severe functional mitral regurgitation who underwent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback